MIFH
BEAM icon

Migdal Insurance & Financial Holdings’s Beam Therapeutics BEAM Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-11,596
Closed -$928K – 591
2021
Q1 		$928K Buy
11,596
+7,196
+164% +$685K 0.01% 250
2020
Q4 		$359K Buy
+4,400
New +$216K ﹤0.01% 241

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Migdal Insurance & Financial Holdings's BEAM Position: Q2 2021 in Review

Migdal Insurance & Financial Holdings sold out of Beam Therapeutics (BEAM) in Q2 2021, closing a stake of 11,596 shares — an estimated $928K sold.

Migdal Insurance & Financial Holdings first reported a position in BEAM in Q4 2020 and held it in 2 quarters. The position peaked at $928K in Q1 2021. 231 funds tracked by Wall St. Rank hold BEAM as of Q2 2021.

  • Migdal Insurance & Financial Holdings reported no remaining Beam Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 11,596 Beam Therapeutics shares in Q2 2021, an estimated $928K.
  • Migdal Insurance & Financial Holdings first reported a position in Beam Therapeutics in Q4 2020 and held it in 2 quarters.
  • Migdal Insurance & Financial Holdings's Beam Therapeutics position peaked at $928K in Q1 2021.
  • 231 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2021.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2021, filed 4 Aug 2021.